
Kossel Medtech develops coronary, peripheral, and electrophysiology interventional devices for hospitals and OEM partners.
kossel-medical.comCrawled Oct 16, 2026
The Bridflex Steerable Introducer Sheath Kit has asymmetric bidirectional bending, a non-radiopaque head end for positioning under fluoroscopy, and a fully woven body designed to provide torque and support.
Cardiac Ablation Catheter is designed for the mapping, recording and pacing of electrophysiological signals.
The Cathfree Steerable Curve Diagnostic Catheter has a smooth bending transition, a soft Pebax head end, and platinum-iridium alloy anodes for recording signals.
The Cathrough Transseptal Needle and Sheath Kit has a rounded needle tip, a smooth shoulder and surface, and a copper-free stainless steel needle hub.
Drug-eluting stents inhibit smooth muscle cell proliferation and reduce restenosis compared with ordinary balloons and bare metal stents, but can delay or prevent endothelial repair and increase the risk of late stent thrombosis.
DEB does not require multiple polymers, does not induce advanced thrombosis, and may reduce the time on dual antiplatelet therapy. It is an alternative when DES treatment is difficult, including for small or curved vessels, diffuse long lesions, bifurcation lesions, and oral lesions.
Percutaneous transluminal coronary angioplasty (PTCA) began modern interventional cardiology in 1977, shifting the field from diagnosis to treatment. Percutaneous coronary intervention (PCI) developed after the first coronary stent implantation in 1986.
NEWS
The 2021 Peking University Vascular Forum was scheduled for October 14–16 in Beijing, China.
On September 28th, 2017, Dr. Hu represented Kossel Medtech make a roadshow in the “Most High-tech Hi-tech Enterprise” contest.
Kossel Medtech received the honorary title of high-tech enterprise in 2016.
Kossel manufactures PTCA balloon dilatation catheters and PTA balloon catheters.
Kossel Medtech (Suzhou) Co., Ltd. lists its telephone, fax, email, WhatsApp number, website, and address as contact options.
Kossel Medtech has the strong technical team and complete production line to develop and produce balloon catheters.
Kossel Medtech offers vascular interventional and implantable products, including PTCA, NC PTCA, CTO, PTA, inflation devices, radial artery tourniquets, diagnostic electrophysiology catheters, cardiac ablation catheters, and vena cava filters. The company is a worldwide supplier.
Kossel focuses on R&D, manufacturing and distributing of cardiovascular interventional medical devices, including balloon catheter, coronary stent delivery system, electrophysiology series products.
The company’s privacy policy describes how it handles personal information and states that visitors can browse the site without providing personal information.
Kossel Medtech and FuseMedTech announce a strategic partnership. The announcement highlights the FuseVive® Pulmonary Artery Thrombectomy System as the anchor of a product portfolio that addresses peripheral vascular embolism, peripheral thrombus removal, and hepatic interventional procedures.
Sep 2026 · Kossel MedtechNews article
Kossel made a significant appearance at this year’s CIRSE congress, showcasing its CE-certified peripheral interventional product portfolio. The displayed products were Falspeed® PTA Balloon Dilatation Catheter, Falexpand® HP PTA Balloon Dilatation Catheter, Tanghulu® PTA Balloon Dilatation Catheter, and Giranel® Guiding Sheath Set.
Sep 2026 · Kossel MedtechNews article
Kossel says four medical devices have received registration from Indonesia’s Ministry of Health, allowing commercial sale in the country. The registrations cover the Falspeed® PTA Balloon Dilatation Catheter, Sabelly® NC PTA Balloon Dilatation Catheter, Falexpand® HP PTA Balloon Dilatation Catheter, and MiSatin® Hydrophilic Guidewire.
Sep 2026 · Kossel MedtechNews article
Kossel Medtech (Suzhou) has a strategic cooperation agreement with Suzhou Silvan Medical concerning the Clothoid Vascular Closure System. The agreement gives Kossel exclusive responsibility for the system’s overseas commercial rollout, with the partnership described as accelerating global commercialization.
Sep 2026 · Kossel MedtechNews article